Related Experiment Video
Updated: Oct 8, 2025
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Crosstalk between Statins and Cancer Prevention and Therapy: An Update
Beniamin Oskar Grabarek1,2,3,4, Dariusz Boroń1,2,3,4, Emilia Morawiec1,5,6
1Department of Histology, Cytophysiology and Embryology, Faculty of Medicine, University of Technology in Katowice, 41-800 Zabrze, Poland.
Abstract:
The importance of statins in cancer has been discussed in many studies. They are known for their anticancer properties against solid tumors of the liver or lung, as well as diffuse cancers, such as multiple myeloma or leukemia. Currently, the most commonly used statins are simvastatin, rosuvastatin and atorvastatin. The anti-tumor activity of statins is largely related to their ability to induce apoptosis by targeting cancer cells with high selectivity. Statins are also involved in the regulation of the histone acetylation level, the disturbance of which can lead to abnormal activity of genes involved in the regulation of proliferation, differentiation and apoptosis. As a result, tumor growth and its invasion may be promoted, which is associated with a poor prognosis. High levels of histone deacetylases are observed in many cancers; therefore, one of the therapeutic strategies is to use their inhibitors. Combining statins with histone deacetylase inhibitors can induce a synergistic anticancer effect.
Insights
Statins exhibit anticancer properties by inducing apoptosis and regulating histone acetylation, offering potential therapeutic benefits. Combining statins with histone deacetylase inhibitors may enhance their anti-tumor effects synergistically.
Area of Science:
- Oncology
- Pharmacology
Background:
- Statins are recognized for their anticancer properties against various solid and diffuse cancers.
- Simvastatin, rosuvastatin, and atorvastatin are commonly used statins with demonstrated anti-tumor activity.
- Statins selectively induce apoptosis in cancer cells, a key mechanism in their anti-cancer effects.
Purpose of the Study:
- To explore the role of statins in cancer therapy.
- To investigate the mechanisms underlying statin's anti-tumor activity, including apoptosis induction and histone acetylation regulation.
- To evaluate the potential of combining statins with histone deacetylase inhibitors for enhanced anti-cancer effects.
Main Methods:
- Review of existing studies on statins and cancer.
- Analysis of the molecular mechanisms of statin action, focusing on apoptosis and histone acetylation.
- Exploration of combination therapy strategies involving statins and histone deacetylase inhibitors.
Main Results:
- Statins demonstrate significant anti-tumor activity against liver, lung, multiple myeloma, and leukemia cancers.
- Statin-induced apoptosis is a primary mechanism of their anti-cancer action.
- Disturbances in histone acetylation, linked to cancer progression, are modulated by statins.
- High levels of histone deacetylases in cancers suggest a therapeutic target.
Conclusions:
- Statins possess valuable anticancer properties, primarily through apoptosis induction and modulation of histone acetylation.
- Combining statins with histone deacetylase inhibitors presents a promising synergistic strategy for cancer treatment.
- Further research into statin-based combination therapies could lead to improved cancer treatment outcomes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:59Cancer Prevention
Some...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:26Atherosclerosis III: Management
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...